← Back to Vista Pharmaceuticals Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

VISTAPHPharmaceuticals

Vista Pharmaceuticals Ltd — Financial Ratios & Key Metrics

₹6.11

+0.00%

P/E RatioN/AxIndustry: 31.77x

ROE-10.83%Return on equity

ROCE-8.53%Return on capital

Debt/Equity0.19Low debt

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹52.93 (Cr)

Sales Growth 5Y

-15.53%

Profit Growth 5Y

-5.94%

EPS Growth 5Y

-0.87%

OPM 5Y Avg

-64.82%

📉

Price Returns

1 Month

-12.42%

3 Months

-13.74%

6 Months

-17.62%

1 Year

-28.21%

52W Low

₹6

Current

₹6

52W High

₹13

5% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹7

▼ Price below SMA 50 — Bearish

SMA 200

₹9

▼ Long-term downtrend

Volume Signal

26% of avg

Below average volume — low conviction

Technical indicators are for educational purposes only. Not investment advice.

More on Vista Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.